459 related articles for article (PubMed ID: 12589162)
1. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
[TBL] [Abstract][Full Text] [Related]
2. Predominant role for C5b-9 in renal ischemia/reperfusion injury.
Zhou W; Farrar CA; Abe K; Pratt JR; Marsh JE; Wang Y; Stahl GL; Sacks SH
J Clin Invest; 2000 May; 105(10):1363-71. PubMed ID: 10811844
[TBL] [Abstract][Full Text] [Related]
3. Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury.
Thurman JM; Royer PA; Ljubanovic D; Dursun B; Lenderink AM; Edelstein CL; Holers VM
J Am Soc Nephrol; 2006 Mar; 17(3):707-15. PubMed ID: 16467447
[TBL] [Abstract][Full Text] [Related]
4. Effect of anti-C5 antibody on recuperation from ischemia/reperfusion-induced acute kidney injury.
Zilberman-Itskovich S; Abu-Hamad R; Stark M; Efrati S
Ren Fail; 2019 Nov; 41(1):967-975. PubMed ID: 31662004
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation.
de Vries B; Matthijsen RA; van Bijnen AA; Wolfs TG; Buurman WA
Am J Pathol; 2003 Jul; 163(1):47-56. PubMed ID: 12819010
[TBL] [Abstract][Full Text] [Related]
6. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury.
de Vries B; Walter SJ; Peutz-Kootstra CJ; Wolfs TG; van Heurn LW; Buurman WA
Am J Pathol; 2004 Nov; 165(5):1677-88. PubMed ID: 15509537
[TBL] [Abstract][Full Text] [Related]
7. Protection of renal ischemia injury using combination gene silencing of complement 3 and caspase 3 genes.
Zheng X; Zhang X; Sun H; Feng B; Li M; Chen G; Vladau C; Chen D; Suzuki M; Min L; Liu W; Zhong R; Garcia B; Jevnikar A; Min WP
Transplantation; 2006 Dec; 82(12):1781-6. PubMed ID: 17198276
[TBL] [Abstract][Full Text] [Related]
8. Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion.
Patel NS; Chatterjee PK; Di Paola R; Mazzon E; Britti D; De Sarro A; Cuzzocrea S; Thiemermann C
J Pharmacol Exp Ther; 2005 Mar; 312(3):1170-8. PubMed ID: 15572648
[TBL] [Abstract][Full Text] [Related]
9. Mice lacking the 110-kD isoform of poly(ADP-ribose) glycohydrolase are protected against renal ischemia/reperfusion injury.
Patel NS; Cortes U; Di Poala R; Mazzon E; Mota-Filipe H; Cuzzocrea S; Wang ZQ; Thiemermann C
J Am Soc Nephrol; 2005 Mar; 16(3):712-9. PubMed ID: 15677308
[TBL] [Abstract][Full Text] [Related]
10. AChE deficiency or inhibition decreases apoptosis and p53 expression and protects renal function after ischemia/reperfusion.
Ye W; Gong X; Xie J; Wu J; Zhang X; Ouyang Q; Zhao X; Shi Y; Zhang X
Apoptosis; 2010 Apr; 15(4):474-87. PubMed ID: 20054652
[TBL] [Abstract][Full Text] [Related]
11. Vaccinia virus complement control protein (VCP) improves kidney structure and function following ischemia/reperfusion injury in rats.
Ghebremariam YT; Engelbrecht G; Tyler M; Lotz Z; Govender D; Kotwal GJ; Kahn D
J Surg Res; 2010 Apr; 159(2):747-54. PubMed ID: 19691975
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs.
Rollins SA; Matis LA; Springhorn JP; Setter E; Wolff DW
Transplantation; 1995 Dec; 60(11):1284-92. PubMed ID: 8525523
[TBL] [Abstract][Full Text] [Related]
13. Posttransplant ischemia-reperfusion injury in transplanted heart is prevented by a minibody to the fifth component of complement.
Ferraresso M; Macor P; Valente M; Della Barbera M; D'Amelio F; Borghi O; Raschi E; Durigutto P; Meroni P; Tedesco F
Transplantation; 2008 Nov; 86(10):1445-51. PubMed ID: 19034016
[TBL] [Abstract][Full Text] [Related]
14. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
Thrane AS; Skehan JD; Thrane PS
Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model.
Spandou E; Tsouchnikas I; Karkavelas G; Dounousi E; Simeonidou C; Guiba-Tziampiri O; Tsakiris D
Nephrol Dial Transplant; 2006 Feb; 21(2):330-6. PubMed ID: 16221709
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment with granulocyte colony-stimulating factor attenuated renal ischaemia and reperfusion injury via activation of PI3/Akt signal pathway.
Li Y; Wu J; Shou Z; He Q; Zhang P; Han F; Li H; Chen J
Nephrology (Carlton); 2008 Dec; 13(6):508-16. PubMed ID: 18331437
[TBL] [Abstract][Full Text] [Related]
17. Notoginsenoside R1 attenuates renal ischemia-reperfusion injury in rats.
Liu WJ; Tang HT; Jia YT; Ma B; Fu JF; Wang Y; Lv KY; Xia ZF
Shock; 2010 Sep; 34(3):314-20. PubMed ID: 20023602
[TBL] [Abstract][Full Text] [Related]
18. Role of complement component C5 in cerebral ischemia/reperfusion injury.
Costa C; Zhao L; Shen Y; Su X; Hao L; Colgan SP; Stahl GL; Zhou T; Wang Y
Brain Res; 2006 Jul; 1100(1):142-51. PubMed ID: 16780818
[TBL] [Abstract][Full Text] [Related]
19. Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury.
de Vries B; Walter SJ; von Bonsdorff L; Wolfs TG; van Heurn LW; Parkkinen J; Buurman WA
Transplantation; 2004 Mar; 77(5):669-75. PubMed ID: 15021827
[TBL] [Abstract][Full Text] [Related]
20. The effect of C1 inhibitor on intestinal ischemia and reperfusion injury.
Lu F; Chauhan AK; Fernandes SM; Walsh MT; Wagner DD; Davis AE
Am J Physiol Gastrointest Liver Physiol; 2008 Nov; 295(5):G1042-9. PubMed ID: 18787060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
